
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF). The vaccine has not been tested in Phase 3 or larger clinical trials.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2DROOUl
via
IFTTT
0 comments:
Post a Comment